The ninth component of complement (C9) is responsible for the cytotoxic action of complement. It is, therefore, an important component of the immune system. C9 is a 70 Kda glycoproteins which in order to be effective must change from a stably folded, water soluble protein into an intrinsic membrane protein. The nature of this transformation must be understood to appreciate how this protein functions. To gain such information a thorough investigation of the structure C9 in its native water soluble form and in its membrane bound form will be initiated. Information static structures will be obtained by surface mapping, EPR and fluorescence spectroscopy, electron microscopy and 3-D image reconstruction, and small angle neutron scattering. The kinetics of structural changes as they occur when the protein enters a membrane will be followed by EPR and fluorescence spectroscopy. All techniques will benefit from labeling of the protein with specific probes. In the past specific labeling was limited by the small number of sites available on a protein. However, this problem can now be circumvented to some extend by site-directed mutagenesis and the use of newer spectroscopic techniques of sufficient sensitivity to examine small amounts of mutant proteins. The approach is to employ genetically engineered labeling sites in the C9 sequence for the attachment of labels.
The specific aims for the next grant period are: 1. To identify the peptide region necessary for hemolytic function by generation of C9 mutants with free cysteines for site-specific attachment of labels, and of hybrid molecules composed of segments from lytic (human) and non-lytic (horse) C9 molecules. 2. To determine the presence (or absence) of transmembrane regions in membrane-bound C9 by mapping of the surfaces of native C9 and membrane- bound C9 with immunologic, enzymatic and spectroscopic methods. 3. To identify contact sites between C8 and C9 and to measure the kinetics of C9 refolding and insertion into membranes. 4. To generate a low resolution structure of membrane-bound C9 by 3- dimensional image reconstruction and by small angle neutron scattering combined with contrast variation procedures.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI019478-13
Application #
2060930
Study Section
Biophysical Chemistry Study Section (BBCB)
Project Start
1982-04-01
Project End
1997-03-31
Budget Start
1994-04-01
Budget End
1995-03-31
Support Year
13
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Missouri Kansas City
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
800772162
City
Kansas City
State
MO
Country
United States
Zip Code
64110
Wang, Y; Bjes, E S; Esser, A F (2000) Molecular aspects of complement-mediated bacterial killing. Periplasmic conversion of C9 from a protoxin to a toxin. J Biol Chem 275:4687-92
Thielens, N M; Enrie, K; Lacroix, M et al. (1999) The N-terminal CUB-epidermal growth factor module pair of human complement protease C1r binds Ca2+ with high affinity and mediates Ca2+-dependent interaction with C1s. J Biol Chem 274:9149-59
Rossi, V; Bally, I; Thielens, N M et al. (1998) Baculovirus-mediated expression of truncated modular fragments from the catalytic region of human complement serine protease C1s. Evidence for the involvement of both complement control protein modules in the recognition of the C4 protein substrate. J Biol Chem 273:1232-9
Esser, A F; Tarnuzzer, R W; Tomlinson, S et al. (1996) Horse complement protein C9: primary structure and cytotoxic activity. Mol Immunol 33:725-33
Tomlinson, S; Wang, Y; Ueda, E et al. (1995) Chimeric horse/human recombinant C9 proteins identify the amino acid sequence in horse C9 responsible for restriction of hemolysis. J Immunol 155:436-44
Esser, A F (1994) The membrane attack complex of complement. Assembly, structure and cytotoxic activity. Toxicology 87:229-47
Esser, A F; Thielens, N M; Zaccai, G (1993) Small angle neutron scattering studies of C8 and C9 and their interactions in solution. Biophys J 64:743-8
Tomlinson, S; Ueda, E; Maruniak, J E et al. (1993) The expression of hemolytically active human complement protein C9 in mammalian, insect, and yeast cells. Protein Expr Purif 4:141-8
Tomlinson, S; Stanley, K K; Esser, A F (1993) Domain structure, functional activity, and polymerization of trout complement protein C9. Dev Comp Immunol 17:67-76
Tomlinson, S; Esser, A F (1992) Rapid immunological screening for protein expression in yeast transformants. Biotechniques 13:710-1

Showing the most recent 10 out of 27 publications